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Abstract
Background: Editing and mutations in microRNAs (miRNAs) can change the stability of pre-miRNAs and/or
complementarities between miRNAs and their targets. Small RNA (sRNA) high-throughput sequencing (HTS) profiles
contain miRNAs that are originated from mutated DNAs or are edited during their biogenesis procedures. It is largely
unknown whether miRNAs are edited in colon tissues since existing studies mainly focused their attention on the
editing of miRNAs in brain tissues.
Results: Through comprehensive analysis of four high-throughput sequencing profiles of normal and cancerous
colon tissues, we identified 548 editing and/or SNPs in miRNAs that are significant in at least one of the sequencing
profiles used. Our results show that the most abundant editing events of miRNAs in colon tissues are 3’-A and 3’-U.
In addition to four known A-to-I editing sites previously reported in brain tissues, four novel A-to-I editing sites are
also identified in colon tissues.
Conclusions: This suggests that A-to-I editing of miRNAs potentially is a commonly existing mechanism in different
tissues to diversify the possible functional roles of miRNAs, but only a small portion of different miRNAs are edited by
the A-to-I mechanism at a significant level. Our results suggest that there are other types of editing in miRNAs
through unknown mechanisms. Furthermore, several SNPs in miRNAs are also identified.
Introduction
MicroRNAs are non-coding RNAs that regulate the
expression of protein-coding genes mainly at the post-
transcriptional level in plants and animals [1]. MiRNAs
have been shown to be edited in multiple ways during
their biogenesis [2-14] A widely studied editing is Adeno-
sine-to-Inosine (A-to-I) editing, which is induced by
ADAR (adenosine deaminase) on double strand RNAs
[12,15]. A-to-I editing converts adenosine residues to ino-
sine residues, which function the same as guanosines
[4,11,12]. A-to-I editing can either affect the biogenesis of
miRNAs [16-18] or the specificity of miRNA:target
complementarity [19]. Another kind of editing happens at
the 3’ end of mature miRNAs. PAPD4 induced 3’ editing
of some miRNAs results in adenylation at 3’ end of
miRNA:miRNA* duplex [7], which potentially interferes
the loading of miRNA into RNA-induce silencing complex
(RISC). Recently, more evidence showed that the 3’ end of
some pre-miRNAs are undergoing another type of editing,
called mono-uridylation, in which several terminal uridylyl
transferases (TUT7, TUT4, TUT2/PAPD4 [13] and TUT1
[20]) introduce an additional U on pre-miRNAs with one
nucleotide overhang at 3’ end. The mono-uridylation
increases the express levels of some miRNAs by facilitating
a two nucleotide overhang for Dicer processing [13].
Single Nucleotide Polymorphism (SNP) is a common
type of DNA sequence variation throughout the human
genome. Similar to editing in miRNAs, SNPs in miRNA
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genes can affect the function of them by modulating the
transcription of the primary transcripts, processing of pri-
miRNAs and pre-miRNAs, maturation, or miRNA:target
interactions [21,22]. Consequently, the SNPs in miRNAs
lead to various diseases, such as chronic lymphocytic leu-
kemia [23], papillary thyroid carcinoma [24], progressive
hearing loss [25], and breast cancer [26,27]. Several studies
focused on the identification of SNPs in human miRNAs
[28-34] have found thousands of SNPs in the pre-miRNAs.
With the fast growth of high throughput sequencing
(HTS) technologies, the whole transcriptomes of small
RNAs (sRNAs) have become easily available. The huge
number of reads from the HTS profiles of sRNAs contain
miRNAs that are different from their DNA template,
which may caused by either mutations in DNAs or editing
on RNAs. Some studies have started to explore the
miRNA editing with HTS profiles of sRNAs [5-8,10-13,18]
However, the existing methods mainly focused discovery
of editing sites, especially A-to-I editing, in brain tissues.
The editing of miRNAs in other tissues are still awaiting
more researches.
Here, we performed a comprehensive analysis for four
sRNA HTS profiles of human colon normal and cancerous
samples. Our results show that four editing sites pre-
viously identified in brain tissues are also identified in
colon tissues. Furthermore, we identified several novel
miRNA editing sites, including 4 canonical A-to-I editing
sites and several editing sites of other types caused by
unknown mechanisms. In addition to these editing of




We used four sRNA HTS profiles of cancer and adjacent
normal tissues of two stage III colorectal cancer (CRC)
patients downloaded from the NCBI Gene Expression
Omnibus http://www.ncbi.nlm.nih.gov/geo under series
accession number GSE43550 (Shi, Zheng, Ren, Han and
Wang, unpublished). One patient underwent surgical
resection of CRC tumor directly and the other patient
underwent Transcatheter Arterial Infusion chemotherapy
(TAI) 1 week before surgical resection. Then, the tumor
and adjacent normal samples were used to perform sRNA
HTS sequencing using Illumina HiSeq2000 sequencer by
following the corresponding protocols. The sequencing
profiles of the patient without TAI are named as
N_no_TAI (adjacent normal tissue) and T_no_TAI (can-
cerous tissue), respectively, and the profiles of the patient
with TAI are named as N_with_TAI (adjacent normal tis-
sue) and T_with_TAI (cancerous tissue), respectively.
The genome sequences of human were downloaded
from UCSC Genome Browser http://genome.ucsc.edu/.
The sequences and genomic coordinates of miRNA
precursors and mature miRNAs were downloaded from
the miRBase release 19 http://www.mirbase.org.
Preprocessing of small RNA HTS sequencing profiles
The original reads with a low-scored 3’ tails were
removed firstly. This step is to make sure the clear 3’
ends of reads. Then, a self-written program was used to
remove the 3’ adapters. Then, the unique reads with at
least 18 nucleotides and their counts were obtained with
self-written programs. The four processed profiles con-
sisted of 15 to 25 million reads, representing 374 to 789
thousand unique sequences.
Main computational steps
The first step is to align unique reads in sRNA profiles to
the pre-miRNAs with NCBI BLASTN. The second step is
to obtain the reads mapped to pre-miRNAs. Next, these
mapped reads are aligned to the genome with Bowtie [35].
Then, the result of Bowtie is further process to add fre-
quencies of reads and to remove reads with more than
100 aligned loci in the genome. Then, the processed result
of Bowtie was analyzed for the possible cross mapping
issues of reads with multiple loci in the genome by using
the method introduced by de Hoon et al., [6].
Next, we analyzed the mutation and editing (M/E) sites
in pre-miRNAs by using several inputs, including the
sequences and secondary structure of pre-miRNAs (pre-
dicted by RNAfold [36]), the alignments of reads to pre-
miRNAs generated by BLASTN, the reads mapped to pre-
miRNAs, the alignments of reads against genome gener-
ated by Bowtie, and the results of the cross mapping
method [6]. In this step, we employed the alignment of
BLASTN to obtain the list of read mapped to a pre-
miRNA. We then used a modified Smith-Waterman algo-
rithm to align an sRNA read to a pre-miRNA sequence.
Briefly, matched and mismatched nucleotides received
rewards of +4 and -3, respectively, in alignment. The affine
gap penalty, i.e., the penalty increasing linearly with the
length of gap after the initial gap opening penalty, was
used for gap opening (-4) and gap extension (-2). The
weight of reads were retrieved from the results of the cross
mapping method [6]. Reads with more than 100 loci were
removed before applying the cross mapping method [6].
Thus, we used the initial alignment of reads to the genome
generated with Bowtie to examine whether a read had
matched loci in genome if it did not appeared in the results
of the cross mapping method, or named as missed reads. If
a missed read had loci with better alignment scores than
its alignment between a pre-miRNA or more than 100 loci
of the same alignment scores as its alignment between a
pre-miRNA, it was neglected. Otherwise, a missed read
was evenly divided to different mapped loci. Then, the
results were compared to reported SNPs [34] and editing
sites in the DARNED database [37] in miRNAs.
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The targets of hsa-miR-6503-3p and edited hsa-miR-
6503-3p were predicted with the HitSensor algorithm
[38]. Predicted targets with at least 7 continuous Wat-
son-Crick matches in the seed regions were maintained
in the analysis.
P-values of identified mutation and editing sites
The quality of identified M/E sites were evaluated using










Where po is the observed percentage of mutated and/or
edited reads, pe is the expected error rate, and n is the
number of reads matched to the position of pre-miRNA.
Since Z follows a standard normal distribution, P-values of
the identified editing or mutation sites can be calculated.
pe is related to the score of sequenced nucleotides. For
example, a phred score of 20 will lead to an expected pe of
1%. Because there could be many mutation and editing
sites, the obtained P-values were corrected with the Benja-
mini-Hochberg correction method [39].
Criteria used to identify significant mutation and editing
sites
Chiang et al., [5] proposed three criteria to evaluate the
editing sites of miRNAs, i.e., if (i) the relative level of edit-
ing is at least 5%; (ii) at least 10 reads support the editing
site; and (iii) the editing site is not in the last two positions
at the 3’ end of mature miRNAs, then the miRNA position
was considered to be edited. In addition to the first two
criteria of Chiang et al., [5], two more criteria is used in
this study, i.e., (i) the score threshold of sequencing reads
is 20; and (ii) a multiple-test corrected P-value of smaller
than 0.05. The third criterion of Chiang et al., [5] was not
used here because our aim is to identify all editing and
mutation sites, including 3’ editing sites, in miRNAs.
The naming of the editing and mutations in miRNAs
All identified M/E sites are named by the names of the
pre-miRNAs, positions of the sites, the nucleotides from
the reference pre-miRNA sequences and the edited/
mutated nucleotide at the sites. For example, hsa-mir-
376a-1_49_A_g is used to mean an A-to-I editing detected
at the position 49 of the hsa-mir-376a-1 precursor, the
position of the reference sequence is “A” and the edited
reads have “g” at this site.
Results and discussion
The identified mutation and editing sites
We totally identified 548 M/E sites of pre-miRNAs that
are significant in at least one of the four sequencing
profiles used (in additional file 1 Table S1), with around
420 M/E sites in each of the four profiles (see Figure 1).
As shown in Figure 1A, 312 M/E sites were commonly
identified in all four libraries, suggesting a good repeatabil-
ity of the identified M/E sites.
Based on the mechanisms of editing or mutation, we clas-
sified these significant M/E sites into eight categories as
shown in Figure 1B. In addition to editing types with
clearly defined mechanisms, i.e., 3’-A, 3’-U, A-to-I and C-
to-U, and SNPs, a few other editing sites happened at 3’
end of mature miRNAs (classified as 3’-Other in Figure
1B) and other positions of miRNAs (classified as Other)
were also identified. We also found that a few editing sites
were incorrectly predicted by the reads that were mapped
to several loci in the genome. In our analysis, reads with
multiple loci might have very small weights, less than 0.05,
on loci that were unlikely to generate these reads after
applying the cross-mapping correction method [11]. How-
ever, the high abundances of these multiple loci reads
could still make the editing site become significant
because the numbers of the true reads mapped to these
loci were relatively small when compared to these incor-
rectly mapped reads with multiple loci. Thus, these sites
were classified as pseudo sites (as Pseudo. in Figure 1B).
Identification of 3’ editing events
The most abundant editing events are 3’-U and 3’-A in all
libraries (Figure 1B). In contrast to the reported predomi-
nant 3’-U in mature miRNAs from 3’ arm of their hair-
pins [7], our results suggest that a substantial number, 65,
of mature miRNAs in the 5’ arm also have 5’-U addition
(additional file 2 Table S2). Furthermore, 81 mature miR-
NAs on the 5’ arm of their hairpins have 3’-A (additional
file 2 Table S2), such as most of the let-7 family members,
suggesting that 3’ end editing of some miRNAs might
happen after the miRNA:miRNA* duplex is formed but
before being loaded into the RISC, which is also noticed
in literature [7]. Our results of 3’-A on the 5’ arm of let-7
family members are also consistent with results in
another study [13].
Some miRNAs have 3’-U and 3’-A addition on both the
5’ and 3’ mature miRNAs (additional file 2 Table S2 and
additional file 3 Figure S1). For example, hsa-mir-143 has
3’-U and 3’-A at end of both miR-143-5p and miR-143-3p
(see additional file 1 Table S1). The 3’ editing on mature
miRNAs of the 3’ arm of their pre-miRNAs might be
added after the pre-miRNA hairpins are formed but before
being cut to miRNA:miRNA* duplex by Dicer [7].
Our results show that same miRNAs may have 3’-U and
3’-A at the same positions. For examples, position 33 of
hsa-miR-146b, position 48 of hsa-miR-192, and position
37 of hsa-miR-584 locate before the central loop regions
and have both 3’-U and 3’-A sites in N_no_TAI and
T_no_TAI samples.
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In summary, these results suggest that the enzymes that
contributes to 3’-A (PAPD4 [7]) and 3’-U (TUT7, TUT4
and PAPD4/TUT2 [13]) may share redundant roles in
adding U or A to the end of miRNAs. In fact, the same
enzyme may catalyze the addition of both uridine and ade-
nine. As reported previously, PAPD4, also known as
TUT2, could introduce both 3’-A [7] and 3’-U editing [13]
to miRNAs.
In addition to the 3’-U and 3’-A, our results suggest that
some miRNAs also have 3’-G and 3’-C editing. For exam-
ples, there are 3’-G addition immediately after hsa-miR-
145-3p and hsa-miR-10a-5p (additional file 4 Figure S2A,
C and S2B,F). In the mean time, these positions also have
3’-A editing (additional file 4 Figure S2D and G). Further,
there are 3’-C at the same position after hsa-miR-145-3p
(additional file 4 Figure S2E). Furthermore, hsa-miR-194-2
and hsa-miR-21 also have 3’-C after their 3’ mature miR-
NAs (additional file 5 Figure S3). As reported previously
[7,9], 3’-G and 3’-C also happens in some miRNAs in
other tissues or cell lines, however their biological rele-
vance is still unclear.
As previously noticed in other tissues, cell lines, and spe-
cies [7], our results show that the 3’-U and 3’-A addition
of miRNAs are also present in colon cancerous and adja-
cent normal tissues.
A-to-I editing of miRNAs in colon tissues
As shown in Table 1, we totally identified 14 editing sites
in pre-miRNAs that satisfy a combination of criteria, i.e.,
at least ten edited reads, an edited reads percentage of at
least 5%, and a multiple-test corrected P-value of less than
0.05, in at least one of the four sequencing profiles used.
8 out of the 14 editing sites are A-to-I editing, repre-
senting the largest category. As shown in Table 1, four
of these 8 A-to-I sites had been reported previously in
brain tissues [3,4].
Four newly identified A-to-I editing sites are shown in
Figure 2. hsa-let-7a-a_28_A_g in Figure 2A is close to 3’
end of mature let-7a-2. But as shown in Figure 2E, 84
reads with 26 to 29 nucleotides at this locus clearly
demonstrate that this is unlikely to be an 3’ addition site
since there are as many as 5 nucleotides after this A-to-I
site. As shown in Figure 2B to 2D, these three editing sites
all happen in the regions of mature miRNAs. As reported
previously, UAG is a preferred motif for A-to-I editing
[3,4,11]. The newly identified A-to-I editing sites also have
a preference for UAG motif. Three newly identified sites
have a local motif of UAG, as shown in Figure 2E to 2G,
and hsa-miR-378b_53_A_g has a local motif of AAG,
which is also frequently modified as noticed previously [4].
Existing studies of miRNA editing mainly focused their
attention on the A-to-I sites in brain tissues of mammals
[5,11,12]. Here our results show that there are some edit-
ing sites, including a few A-to-I sites, in colon cancer and
corresponding adjacent normal tissues. This suggests that
miRNA editing is potentially a widely used mechanism to
realize more diverse roles of miRNAs in different tissues
and organs. However, only a limited number of miRNAs
are edited by the A-to-I mechanism which is similar to
previous results in brain [11].
Figure 1 The number of significant M/E sites in miRNAs and their categories in the analyzed sRNA libraries.
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Our results indicate that four known A-to-I editing sites
on hsa-miR-376a-1, hsamiR-376a-2, hsa-miR-376c and
hsa-miR-411 are also edited in normal and/or cancerous
colon tissues, although existing studies mainly reported
these sites in brain tissues [3,4,11].
Other types of miRNA editing in colon tissues
As shown in Table 1, we detected six non-canonical A-
to-I editing sites in our data sets. Four of them are
shown in Figure 3 hsa-miR-378c_30_-_g in Figure 3A is
an insertion of “g” to the mature hsa-miR-378c. This
Table 1 The identified editing sites in miRNAs in the sequenced stage III CRC samples.
N_no_TAI T_no_TAI N_with_TAI T_with_TAI
ME ID P.P. S.P. W ME MER MEP FDR_P MER MEP FDR_P MER MEP FDR_P MER MEP FDR_P Ref.
hsa-mir-376a-1_49_A _g 49 6 A g 23 89.4 0.00E+00 19 88.7 0.00E+00 28 91.7 0.00E+00 55 92.3 0.00E+00 [3,4]
hsa-mir-376a-2_55_A_g 55 6 A g 23 89.4 0.00E+00 19 88.7 0.00E+00 28 91.7 0.00E+00 55 92.3 0.00E+00 [4]
hsa-mir-376c_48_A_g 48 6 A g 35 35.2 0.00E+00 26 31 0.00E+00 35 38.4 0.00E+00 70 34.5 0.00E+00 [4]
hsa-let-7a-2_28_A_g 28 A g 33 17.1 1.90E-13 41 23.6 0.00E+00 63 29 0.00E+00 34 25.5 0.00E+00
hsa-mir-378b_53_A_g 53 A g 24 92.4 0.00E+00 6 100 0.00E+00 26 95.5 0.00E+00 15 92.3 0.00E+00
hsa-mir-497_83_A_g 83 A g 15 83.3 0.00E+00 3 72.7 3.71E-10 19 85.7 0.00E+00 6 83.3 0.00E+00
hsa-mir-6503_59_A_g 59 7 A g 15 72.7 0.00E+00 6 46.9 3.11E-11 9 62.5 0.00E+00 6 45.5 2.03E-11
hsa-mir-411_20_A_g 20 5 A g 36 4.5 1.00E+00 51 4.8 1.00E+00 43 9.7 4.84E-05 38 5 1.00E+00 [4]
hsa-mir-125b-1_25_C_u 25 C u 226 5.1 1.00E+00 197 6.9 4.28E-05 392 8.9 0.00E+00 191 6.7 3.00E-04
hsa-mir-125b-2_27_C_u 27 C u 225 5 1.00E+00 195 6.8 7.50E-05 392 8.8 0.00E+00 192 6.6 4.69E-04
hsa-mir-141_72_U_g 72 U g 747 5.6 8.11E-03 1034 4.4 1.00E+00 482 4.7 1.00E+00 2067 4.1 1.00E+00
hsa-mir-378c_30_-_g 30 - g 57 21.8 0.00E+00 21 22.7 5.90E-14 55 27.8 0.00E+00 17 32.5 0.00E+00
hsa-mir-429_64_U_g 64 U g 239 6.5 2.05E-04 261 5.4 1.00E+00 149 6.6 2.83E-03 155 5.5 7.63E-01
hsa-mir-375_56_G_c 56 G c 249 1.9 1.00E+00 163 1.2 1.00E+00 610 5.6 2.18E-02 17 1.6 1.00E+00
P.P. and S.P. means the position in pre-miRNA and seed region, respectively. W and ME means the original nucleotide, as in the miRBase, and edited/mutated
nucleotide, respectively. N_no_TAI, T_no_TAI, N_with_TAI (adjacent normal tissue) and T_with_TAI means the sequencing profiles of adjacent normal tissue
without TAI, cancer tissue without TAI, adjacent normal tissue with TAI and cancerous tissue with TAI, respectively. MER, MEP, and FDR_P means the number of
edited reads, the percentage of edited reads, and the FDR-corrected P-value using method of [39], respectively.
Figure 2 The details of four identified A-to-I editing sites in miRNAs. (A) to (D) are schematic views of hsa-miR-378b, hsa-miR-497, hsa-miR-
6503 and hsa-let-7a-2, respectively. In part (A) to (D), the upper panel shows the total number of reads (vertical axis) aligned to positions
(horizontal axis) of the precursors of miRNAs, the central panel shows the number of reads that do not match the reference precursor sequences
of miRNAs, the lower panel shows - log10 of the multiple-test corrected P-value (with Benjamini and Hochberg [39] method) of the editing or
mutation sites. The meaning of different colors in the central and lower panels are given at the lower right corner. (E) to (H) are the reads
supporting hsa-miR-378b_53_A_g, hsa-miR-497_83_A_g, hsa-miR-6503_59_A_g and hsa-let-7a-a_28_A_g, respectively. In part (E) to (H), the lower
case nucleotides in the reads mean the mismatched nucleotides that are generated in editing or mutation events; and the upper case
nucleotides in the precursors mean the mature miRNAs. The three columns after a read are the original number of this read in the library, the
length of the read, and the weight of this read at this locus calculated by the cross mapping algorithm [11]. The percentage values after the
name of editing site are the percentage of edited or mutated reads. The lines below the pre-miRNA sequences are the secondary structures
predicted with RNAfold [36], and numbers in the parent thesis mean the minimum free energy in k-cal/mol. In all parts, the names of the
sequencing profiles are shown in the parenthesis after the name of the editing sites.
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editing contributes to 21.8% to 32.5% of the sequenced
reads of hsa-miR-378c and is significant in all four
sequencing profiles used (Table 1), suggesting that a few
miRNAs may have insertions after being transcribed.
However, the mechanism of this editing still needs
further researches.
C-to-U editing is detected in hsa-miR-125b-1 and hsa-
miR-125b-2 in all four sequencing libraries analyzed
(Table 1 and Figure 3B). Previous studies also found sev-
eral miRNAs, such as miR-379, miR-140*, and miR376a,
may have C-to-U editing, probably occurring only in preor
mature miRNAs [12].
Two U-to-G editing are detected at hsa-miR-141 and
hsa-miR-429 (Figure 3C and 3D). And hsa-miR-375 has
an G-to-C editing at position 56 of its precursor (Table
1). Similar to the insertion at hsa-miR-378c, the
mechanisms of these several editing sites are still
unclear and need more studies. Another possible reason
for the three non-canonical A-to-I editing in Figure 3F,
G and 3H are SNPs. However the low percentages of
M/E reads from these loci suggest that these sites are
unlikely to be inherited SNPs, and at most they could
be somatic SNPs.
Identification of SNPs in miRNAs in the samples used
We identifies four significant SNP sites as shown in Fig-
ure 4. hsa-miR-1304_65_C_a, corresponding to SNP
rs2155248, universally appears in all four samples with
100% mutated/edited reads percentage (Figure 4A and
4E).
hsa-miR-196a-2_78_C_u, corresponding to an SNP
rs11614913, is only significant in the T_no_TAI sample
(Figure 4B and 4F). 76.9% reads covering this SNP are
mutated in this sample (Figure 4F). Previous study
showed that rs11614913 in hsa-miR-196a-2 reduced the
expression level of miR-196a, and was significantly asso-
ciated with decreased breast cancer risk [26]. Other
researches also reported that the high levels of miR-
196a may promote oncogenic phenotype of colorectal
cancer cells [40] and non-small cell lung cancer cell
[41]. The appearance of mutated hsa-miR-196a-2 in the
T_no_TAI sample does not agree with the oncogenic
roles of hsa-miR-196a-2, suggesting that the tumor gen-
esis of this patient may caused by other biological
pathways.
hsa-miR-629 31 G c is caused by an SNP rs78212770
(Figure 4C and 4G) and does not shown in two samples
N_no_TAI and T_no_TAI. 31.0% and 21.1% reads in the
N_with_TAI and T_with_TAI samples from this locus are
mutated (see Figure 4G), suggesting it is a somatic muta-
tion in this patient.
hsa-miR-3662a_62_G_a caused by an SNP rs66683138
appears in 100% reads from this locus in the N_with_-
TAI sample (Figure 4D and 4H). Other samples also
have a few reads that support the existence of this SNP
in those samples.
In addition to the four SNPs in Figure 4, our results also
suggest that hsa-miR-3676_62_G_a is a potential SNP
since it happens with 100% reads from this locus in all
four libraries (see additional file 1 Table S1 and additional
file 6 Figure S4). hsa-miR-3676 is annotated as a tRNA
since release 20 of the miRBase. Thus, this result indicates
that small RNA sequencing profiles potentially could be
used to find SNPs in tRNAs as well.
Figure 3 The details of four non-A-to-I identified editing sites in miRNAs. (A) to (D) are the schematic views of hsa-miR-3653, hsa-miR-194-
2, hsa-miR-378c and hsa-miR-21, respectively. (E) to (H) are the reads supporting hsa-miR-3653_42_C_u, hsa-miR-194-2_37_A_c, hsa-miR-
378c_30_-_g, and hsa-miR-21_32_G_c, respectively. Legend idem to those of Figure 2.
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The targets of edited hsa-miR-6503-3p
As shown in Table 1 and Figure 2C and 2G, there is an
A-to-G editing site in the seed region of hsa-miR-6503-
3p which will potentially change the complementarities
between this miRNA and its targets. Thus, we predicted
the potential targets for both original hsa-miR-6503-3p
and edited hsa-miR-6503-3p. As shown in Figure 5, hsa-
miR-6503-3p has 717 targets but the edited hsa-miR-
6503-3p only has 293 targets, and original and edited
hsa-miR-6503-3p only shared 4 targets. These results
suggest that the A-to-I editing at position 7 of the seed
of hsa-miR-6503-3p severely changes the complementa-
rities between this miRNA and its targets, and changes
the function of hsa-miR-6503-3p.
Figure 4 The details of four identified SNPs in miRNAs. (A) to (D) are the schematic views of hsa-miR-1304, hsa-miR-196a-2, hsa-miR-629 and
hsa-miR-3676, respectively. (E) to (H) are the reads supporting hsa-miR-1304_65_C_a, hsa-miR-196a-2_78_C_u, hsa-miR-629_31_G_c and hsa-miR-
3662a_21_G_a, respectively. Legend idem to those of Figure 2. In part (E) to (H), the corresponding rs ID of the SNPs are given after the ID of
the M/E site.
Figure 5 The number of targets of hsa-miR-6503-3p (blue circle) and edited hsa-miR-6503-3p (yellow circle).
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Conclusion
Our results suggest that some miRNAs are edited in
colon tissues after analyzing four colon normal or can-
cerous small RNA HTS sequencing profiles. 3’-A and 3’-
U are the two most common editing events in the
examined tissues. Four novel A-to-I editing sites on
miRNAs, as well as another four A-to-I editing sites pre-
viously reported in brain tissues, are characterized in
colon normal and/or cancerous tissues. Several editing
sites of other types are also identified, however their
mechanisms need more researches. Our results identify
four SNPs that universally appeared with M/E read per-
centages of 100% in all of the four samples used or with
less than 100% M/E reads percentages in some of the
samples used, suggesting inherited or somatic mutations
respectively.
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Additional File 4: Figure S2 – The examples of 3’-G editing of
miRNAs. (A) and (B) are schematic views of hsa-miR-145 and hsa-miR-
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21, respectively. (C) to (D) are the reads supporting hsa-miR-194-
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